Yale Cancer Center appoints 1st chief of hematologic malignancies

Yale Cancer Center in New Haven, Conn., has appointed Amer Zeidan, MD, as its inaugural chief of the division of hematologic malignancies. 

Advertisement

Dr. Zeidan is an expert in acute myeloid leukemia and myelodysplastic syndromes, and is the author of more than 330 peer-reviewed publications. He joined the faculty at Yale in 2014 and was promoted to associate professor in 2019. 

In addition to his new role, Dr. Zeidan will continue to lead the leukemia program and retain his position as assistant director of the clinical trials office. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.